TYK Medicines, Inc. announced that it has received nearly CNY 200 million in a round of funding led by new investor Sichuan Huiyu Pharmaceutical Co., Ltd. on December 28, 2023. The transaction included participation from new investors CICC Capital Management Co., Ltd., Huzhou Talent Fund, returning investor Zhejiang Changxing Financial Holding Group Co., Ltd., and other well-known institutions.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.48 CNY | -2.11% | +2.20% | -10.91% |
05-15 | China Grants Drug Registration for Huiyu Pharma's Two Injectables | MT |
04-26 | Sichuan Huiyu Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
-10.91% | 787M | |
+50.70% | 791B | |
+41.96% | 630B | |
-7.15% | 350B | |
+18.77% | 328B | |
+8.79% | 298B | |
+18.02% | 246B | |
+1.27% | 225B | |
+11.95% | 218B | |
+3.68% | 160B |
- Stock Market
- Equities
- 688553 Stock
- News Sichuan Huiyu Pharmaceutical Co., Ltd.
- TYK Medicines, Inc. announced that it has received funding from Sichuan Huiyu Pharmaceutical Co., Ltd., CICC Capital Management Co., Ltd., Zhejiang Changxing Financial Holding Group Co., Ltd., and other investors